| Anthony Timothy Culbertson, PHARMD | |
|
9451 Dunkirk Ln N, Maple Grove, MN 55311 | |
| (763) 416-2300 | |
| Not Available |
| Full Name | Anthony Timothy Culbertson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 9451 Dunkirk Ln N, Maple Grove, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043924889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 125798 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anthony Timothy Culbertson, PHARMD 4755 Park Commons Dr Apt 222, St Louis Park, MN 55416-4294 Ph: (763) 567-0950 | Anthony Timothy Culbertson, PHARMD 9451 Dunkirk Ln N, Maple Grove, MN 55311 Ph: (763) 416-2300 |
News Archive
NANOBIOTIX, a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the U.S. Food and Drug Administration has approved its Investigational New Drug Application for NBTXR3, a first-in-class nanoparticle designed for direct injection into cancerous tumors, activated by stereotactic ablative radiotherapy (SABR) and administered in combination with an anti-PD1 antibody (nivolumab or pembrolizumab).
Research has shown that participating in home, school and community activities has a positive influence on a person's health and wellbeing.
A Dutch study that included nearly 90,000 women finds that liquid-based cytology, a commonly used alternative to conventional Pap tests, is not superior to Pap tests for the detection of cervical cancer precursors or cancer, according to a study in the October 28 issue of JAMA.
New findings from a phase 1 trial presented yesterday at the 53rd Annual American Society of Hematology (ASH) Annual Meeting demonstrate Micromet's blinatumomab induces durable responses in patients with extensively pre-treated diffuse large B cell lymphoma.
Two medical imaging techniques, called positron emission tomography (PET) and computed tomography (CT), could be used in combination as a biomarker to predict the effectiveness of antibiotic drug regimens being tested to treat tuberculosis (TB) patients, according to researchers at the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 4 days ago
Dr. Jennifer Mertz Riegel, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 14500 99th Ave N, Maple Grove, MN 55369 Phone: 763-898-1806 | |
James Vincent Reineke, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6300 Wedgewood Rd N, Maple Grove, MN 55311 Phone: 763-551-1215 | |
Dr. Mark Solomon Kerbel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6445 Ranchview Ln N, Maple Grove, MN 55311 Phone: 763-898-8133 | |
Zeleke Belay Goshu, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15300 Grove Cir N, Maple Grove, MN 55369 Phone: 763-447-2507 | |
Lisa Winter, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10150 Niagara Ln N, Maple Grove, MN 55369 Phone: 763-220-1316 | |
Charles Flahave, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6300 Wedgwood Rd N, Maple Grove, MN 55311 Phone: 763-551-1215 |